NORCET -4 , 2023: Which of the following is an indication of phototherapy in a new born with hyperbilirubinemia?

NORCET -4 , 2023

Child Health Nursing (Pediatrics)

Medium

Appeared in: NORCET -4 , 2023

Explanation

The decision to start phototherapy is based on the newborn's total serum bilirubin (TSB) level, age in hours, and risk factors.
A TSB level of 15 mg/dL is a common threshold for initiating phototherapy in a healthy term infant, especially within the first 24-48 hours of life.
Starting treatment at this level helps prevent the bilirubin from rising to more dangerous levels that could lead to kernicterus (brain damage).
This value represents a key action point in the management of neonatal jaundice, shifting from observation to active treatment.

Option A: A bilirubin level of 12.5 mg/dL in a healthy term newborn is typically just above the physiological peak and is usually managed with close observation and ensuring adequate feeding to promote bilirubin excretion. It is generally below the threshold for initiating phototherapy.
Option C: While a bilirubin level of 20 mg/dL is a definite indication for intensive phototherapy, it represents a more severe level of hyperbilirubinemia. At this point, the primary concern is preventing the need for an exchange transfusion.
Option D: A bilirubin level of 22 mg/dL is a critically high value. It requires immediate, intensive phototherapy and is very close to or at the threshold for an exchange transfusion, which is a more invasive procedure to rapidly lower bilirubin levels.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Management of neonatal hyperbilirubinemia and indications for phototherapy as background academic context rather than a clinical decision trigger.
Nurses must use hour-specific bilirubin nomograms to assess the need for phototherapy, rather than relying on a single value, as the risk changes rapidly with the infant's age in hours.
Accurate monitoring during phototherapy is a critical nursing responsibility, including ensuring eye protection, maximizing skin exposure, maintaining thermoregulation, and promoting hydration to facilitate bilirubin excretion.
What if the newborn was preterm (e.g., 34 weeks gestation)? The threshold for phototherapy would be significantly lower. A bilirubin level of 12.5 mg/dL, or even lower, would likely be an indication to start treatment in a preterm infant due to their increased vulnerability to bilirubin neurotoxicity.

How to Approach the Question

First, identify the core of the question: it's asking for a value that triggers phototherapy in a newborn.
Recognize that the indication for phototherapy is not a single number but depends on the infant's age (in hours), gestational age, and health status. The question is simplified and lacks this context.
Evaluate the options in the context of a 'typical' healthy, term newborn. The goal is to find the most common or standard initiation threshold.
Eliminate 12.5 mg/dL as it's often in the observation range.
Recognize that 20 and 22 mg/dL are high, critical levels where phototherapy is mandatory, but another, more aggressive treatment (exchange transfusion) is also being considered. These are points of 'escalation of care,' not the initial trigger.
Select 15 mg/dL as the most plausible answer representing a common point where treatment is started to prevent levels from becoming critical.

Concept Tested & Keywords

Concept Tested: Management of neonatal hyperbilirubinemia and indications for phototherapy.
Stem keywords: phototherapy, new born, hyperbilirubinemia, indication
Lead-in keywords: Which of the following is

QPJ-T0XpACm_znMbCw9hj

E6 Nelson Textbook of Pediatrics(2024) — Volume 1 pp. 1124-1126, 1123-1125